You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
Reply to ‘Hormone use missing from UK Biobank cardiovascular disease study’
  1. Sanne A E Peters1,
  2. Mark Woodward1,2,3
  1. 1The George Institute for Global Health, University of Oxford, Oxford, UK
  2. 2The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia
  3. 3Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA
  1. Correspondence to Dr Sanne A E Peters, The George Institute for Global Health, University of Oxford, Oxford OX1 3QX, UK; sanne.peters{at}georgeinstitute.ox.ac.uk

https://doi.org/10.1136/heartjnl-2018-313141

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The Authors’ reply

    Dr Grant postulates1 that our recent study2 on the association between women’s reproductive factors and the risk of cardiovascular disease (CVD) in later life is limited due to our failure to allow for the impact of contraceptive and menopausal hormone use on our …

    View Full Text

    Footnotes

    • Funding This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent Not required.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles